Zentek (NASDAQ:ZTEK) Given "Sell (E+)" Rating at Weiss Ratings

Key Points

• Zentek (NASDAQ:ZTEK) has been reissued a "sell (E+)" rating by Weiss Ratings as of Wednesday.
• As of the last trading session, Zentek's stock traded at $0.80 with a market capitalization of $83.46 million.
• The company reported a negative net margin of 981.17% and a negative EPS of ($0.01) for the last quarter.

Zentek (NASDAQ:ZTEK - Get Free Report)'s stock had its "sell (e+)" rating reissued by equities research analysts at Weiss Ratings in a report issued on Wednesday,Weiss Ratings reports.

Zentek Stock Performance

Shares of NASDAQ:ZTEK traded down $0.03 during trading on Wednesday, hitting $0.80. 47,140 shares of the company traded hands, compared to its average volume of 132,950. The stock has a market capitalization of $83.46 million, a price-to-earnings ratio of -15.98 and a beta of 0.90. The business's fifty day moving average is $0.83 and its 200-day moving average is $1.12. Zentek has a one year low of $0.50 and a one year high of $1.84. The company has a quick ratio of 1.30, a current ratio of 1.62 and a debt-to-equity ratio of 0.12.

Zentek (NASDAQ:ZTEK - Get Free Report) last posted its earnings results on Thursday, August 14th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.04 million for the quarter. Zentek had a negative net margin of 981.17% and a negative return on equity of 55.41%.

About Zentek

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.